Mark Identification
EGRIFTA WR
Serial Number
97285545
Filing Date
Feb 25, 2022
Trademark by
Classification Information
Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment, traumatic brain injury, nonalcoholic steathohepatitis and nonalcoholic fatty liver disease
Pharmaceuticals